BWX Technologies, Inc. BWXT is scheduled to report fourth-quarter 2024 results after market close on Feb. 24. Stay up-to-date ...

While traveling in Europe, Margaux Lantelme noticed something different about the store cashiers: they did their work sitting ...

The U.S. government's foreign aid freeze has upended the supply chain for medical products crucial for fighting diseases ...

Medical technologies specialist Globus Medical ( GMED 0.04%) reported impressive results for the fourth quarter of 2024 on Thursday, Feb. 20. The highlights included adjusted earnings per share (EPS) ...

BTIG analyst Ryan Zimmerman raised the firm’s price target on Globus Medical (GMED) to $94 from $91 and keeps a Buy rating on the shares after ...

Wells Fargo analyst Vik Chopra lowered the firm’s price target on Globus Medical (GMED) to $93 from $95 and keeps an Overweight rating on the ...

Anaheim, Calif. — Medical manufacturers are seeing overall growth in the market as it continues to rebound from high levels of inventory from the COVID-19 pandemic and responds to new drug development ...

The semaglutide shortage has officially ended in the US—which means the GLP-1 drug industry is about to undergo massive changes.

Ellie Leach was spotted flogging old clothes on Vinted for as little as £4 after revealing she's 'unemployed'.

Federal regulators say shortages of Ozempic and Wegovy have been resolved, as supplies of popular diabetes and obesity treatments continue to improve.